Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Eight-year outcomes of testosterone suppression plus enzalutamide or a nonsteroidal antiandrogen for metastatic hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Patient blood management - a new paradigm for transfusion medicine?
ISBT science series·2020
Junior doctors' perspectives on transfusion education in Australia.
Vox sanguinis·2018